Becton, Dickinson and Company Announces Collaboration With Pain Management And Palliative Care Infusion Pump Specialists, CME Medical, To Further Support The Growing Therapy Area Of Subcutaneous Infusion

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Oxford, UK (08 January 2014) – BD (Becton, Dickinson and Company), a leading global medical technology company, announces that following the approval of the BD Saf-T-Intima™ Safety Integrated IV Catheter System for use in subcutaneous infusion therapies that it will be collaborating with pain management and palliative care infusion pump specialists, CME Medical, to increase coverage in the UK and Ireland and to provide expanded specialist support to its growing Saf-T-Intima™ customer base.

Jonathan Hughes, UK Marketing Manager for BD explains, “BD Saf-T-Intima™, for use in subcutaneous infusion therapies such as rehydration and palliative care, is growing in popularity due to an increasing number of healthcare professionals who are looking for ways to increase patient comfort and in-dwell times while enabling cost savings and reducing the risk of sharps injuries and infection.

With palliative care being a key therapy area for subcutaneous infusion, it was a logical step for BD to collaborate with CME Medical which already has a large and clinically respected presence within Acute and Community Care following the popularity and wide adoption of CME Medical’s T34TM Ambulatory Syringe Pumps.”

For any enquiries relating to BD Saf-T Intima™ in the UK and Ireland please contact CME Medical’s dedicated customer service team on 01253 206330 or email customerservice@cmemedical.co.uk. Routes for procurement of BD Saf-T-Intima™ and BD product codes will remain unchanged.

Related links:
BD’s Healthcare Worker Safety website: www.bd.com/europe/safety/en/
CME Medical www.cmemedical.co.uk

For Product Enquiries Contact:
Heather Williams
European Communications Manager
BD Diagnostics - Preanalytical Systems Europe
00 44 1865 781623

For Media Enquiries Contact:
Laura Blott
PR Account Executive
Lindsell Marketing
00 44 207 402 0510

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people’s health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com

About CME Medical

CME Medical are leaders in the specialist infusion market, distributing portable infusion products to over 300 NHS trusts as well as private hospitals, homecare providers and GP surgeries across the UK and Ireland. CME Medical believes in making clinical practice safer and more efficient through innovation; by listening to its customers and understanding their challenges. Pain management, palliative care, oncology and nutrition are specific areas of innovation in which solutions are provided. Founded in 2001, CME Medical’s head office is in Blackpool, Lancashire, with a multi-skilled support team network operating across the UK. In October 2013, CME Medical became the first infusion product company to obtain the Skills for Health Quality Mark for training. For more information, please visit www.cmemedical.co.uk

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC